For the first time, researchers have identified that an immune cell subset called gamma delta T cells may be causing and/or perpetuating the systemic inflammation found with normal aging among the general geriatric population and in HIV-infected people who are responding well to drugs (anti-retrovirals).
Even with effective viral control, HIV-infected individuals are at a higher risk for diseases associated with older age than the general population. Unfortunately, the cell subsets driving inflammation in HIV infection and with normal aging are not yet understood. Also, whether antiretroviral therapy (ART) suppressed HIV infection causes premature induction of the inflammatory events found in uninfected elderly or if a novel inflammatory network ensues when HIV and older age co-exist is unclear.
To understand the cellular network that drives the onset and progression of age-associated morbidities in both ART-suppressed HIV and healthy aging, researchers from BUSM conducted a study that measured many markers on the surface of immune cells in the blood of people either with or without HIV that were sub-divided into two groups: younger (less than 35 years) and older (over 50 years) and compared that data with levels of inflammatory proteins in their plasma. This unique group of patients was recruited for the study by co-last author Nina Lin, MD, Assistant Professor of Medicine at BUSM and an infectious disease clinician at Boston Medical Center.
Researchers found that a marker on gamma delta T cells, called TIGIT, tracked significantly with plasma inflammatory markers in both the HIV+ and uninfected subject groups, and therefore could be targeted to potentially stop this ‘inflamm-aging’ found in both HIV+ people and the general geriatric population.
“Our study indicates that a previously uninvestigated immune cell subset in the setting of chronic inflammation with aging or HIV infection, gamma delta T cells, could be causing and/or perpetuating many illnesses in the elderly and in individuals with HIV. Therefore, we believe that targeted gamma delta T cell therapeutics could lead to reduced onset, symptoms, and/or severity of inflammation-related diseases,” explained corresponding author Jennifer Snyder-Cappione, PhD, Assistant Professor of Microbiology and Director of the Flow Cytometry Core Facility at BUSM.
More than 50 percent of the HIV-infected population in the U.S. is older than 50 years and the world’s geriatric population over the ages of 65 and 80 is predicted to double and nearly quadruple, respectively, by 2050. “Revealing and then therapeutically targeting the cell populations and precise immune networks that drive ‘inflamm-aging’ both with and without HIV infection is a preeminent global health priority,” added Dr. Snyder-Cappione.
The researchers, which include first author Anna Belkina, MD, PhD, Assistant Professor of Pathology and Laboratory Medicine at BUSM, hope that their study will spur new investigation and clinical trials targeting gamma delta T cell subsets to control unchecked inflammation and thereby reduce the onset and progression of many chronic diseases.
The Latest on: Chronic inflammation
via Google News
The Latest on: Chronic inflammation
- Inflammatory bowel disease during pregnancy associated with poor maternal and fetal outcomeson August 4, 2022 at 7:30 am
Pregnant women with inflammatory bowel disease (IBD) and their babies face increased risks and complications compared to pregnant women without IBD. Those are the findings from a new University ...
- Study finds inflammatory bowel disease increases risk for pregnant womenon August 4, 2022 at 7:05 am
Compared to pregnant women without IBD, pregnant women with inflammatory bowel disease and their unborn children suffer more risks and problems. These are the conclusions of a recent study which ...
- Inflammatory bowel disease increases risk for pregnant women: Studyon August 3, 2022 at 11:15 pm
IBD is a term used for Crohn's disease and ulcerative colitis, which are characterized by chronic inflammation of the gastrointestinal tract. IBD mainly affects young people, which includes women who ...
- 4 Best Drinking Habits To Reduce Inflammation and Slow Agingon August 3, 2022 at 1:21 pm
How can we use our drinking habits to reduce inflammation and slow aging? Our dietitians share their most helpful advice.
- Inflammatory bowel disease increases risks for pregnant womenon August 3, 2022 at 7:29 am
Pregnant women with inflammatory bowel disease (IBD) and their babies face increased risks and complications compared to pregnant women without IBD. Those are the findings from a new University of ...
- Green Tea Extract May Help Reduce Blood Sugar and Gut Inflammationon August 3, 2022 at 6:38 am
Now new research on people with a handful of heart disease risk factors is showing that ingesting green tea extract for four weeks can also reduce blood sugar levels and lower gut inflammation.
- 15 Anti-Inflammatory Dinners You Can Make on a Sheet Panon August 2, 2022 at 11:48 am
These sheet-pan recipes make a healthy and easy option for dinner tonight. By using only one pan, you'll also save time on cleaning up later. These recipes also showcase anti-inflammatory friendly ...
- The Best Juice to Sip on To Reduce Inflammation, Says Dietitianon August 1, 2022 at 12:57 pm
This unexpected juice is highly recommended for sports recovery and reducing inflammation in the body. The post The Best Juice to Sip on To Reduce Inflammation, Says Dietitian appeared first on The ...
- Nanotechnology Could Have a Crucial Role in Inflammatory Bowel Disease Treatmenton July 28, 2022 at 7:45 am
A new review focuses on recent advancements in nanotechnology-based treatments for IBD, mainly targeting inflammation and dysregulated gut microbiomes.
- Hydrogen generated by Si-based agent attenuates inflammation in ulcerative colitis mouse modelon July 25, 2022 at 6:48 am
Many people worldwide suffer from a chronic type of inflammatory bowel disease (IBD) called ulcerative colitis (UC), which is characterized by erosions and ulcers within the mucous membrane of the ...
via Bing News